Sign In
Buy NVO
$47.41
-0.0100 (-0.0211%)
At Close: Jun 24, 2026
2 Rising Biotechs That Could Become the Next Novo Nordisk
02:59am, Monday, 29'th Jan 2024
Novo Nordisk has been a great investment due to its drugs for diabetes and obesity. Madrigal Pharmaceuticals has big plans for treating a serious liver disease known as NASH.
5 top healthcare stocks for earnings growth in 2024
07:09am, Thursday, 25'th Jan 2024
Sector components forecast to show the biggest earnings year-over-year earnings improvement include Humana Inc. NYSE: HUM, Elevance Health Inc. NYSE: ELV, Incyte Corp. NASDAQ: INCY, Insulet Corp.
5 Momentum Stocks to Buy Ahead of Earnings Results
08:31am, Tuesday, 23'rd Jan 2024
We have narrowed our search to five momentum stocks that are poised to beat on earnings results next week. These are: BEN, NVO, CPA, CRS, JHG.
Novo Nordisk (NVO) Stock Dips While Market Gains: Key Facts
06:56pm, Monday, 22'nd Jan 2024
Novo Nordisk (NVO) reachead $105.49 at the closing of the latest trading day, reflecting a -1.37% change compared to its last close.
3 Phenomenal Stock-Split Stocks You Should Be Buying Now
04:30pm, Monday, 22'nd Jan 2024
Stock splits are a bullish sign that management sees more room for growth. Although they technically mean nothing as to the operation of the company, the market still sees them as a positive developme
Novo Nordisk: Outlook For Weight Loss Drugs In 2024
09:15am, Monday, 22'nd Jan 2024
Novo Nordisk's weight loss drug, Wegovy, earned $1.38 billion last quarter and is projected to share a large piece of the growing weight-loss drug market. Despite its market dominance, Novo faces chal
Can TikTok Do for Peloton What It Did for Novo Nordisk and Ozempic?
01:59am, Sunday, 21'st Jan 2024
Peloton is partnering with TikTok in a move that will make its content easier to find. Social media can play a big role in raising awareness around a product, as it did with Ozempic.
3 High-Flying Stocks That Could Soar Even More in 2024
06:50am, Saturday, 20'th Jan 2024
CRISPR Therapeutics stock has room to run higher with the biotech's first therapy on the market. Eli Lilly is now the world's biggest drugmaker and has multiple growth drivers.
Best Growth Stocks to Buy for January 19th
10:06am, Friday, 19'th Jan 2024
ARCO, NVO and ENS made it to the Zacks Rank #1 (Strong Buy) growth stocks list on January 19, 2024.
Best Growth Stocks to Buy for January 16th
11:25am, Tuesday, 16'th Jan 2024
NVO, AIZ and PAX made it to the Zacks Rank #1 (Strong Buy) growth stocks list on January 16, 2024.
4 Pharma Stocks to Buy, According to an Analyst. Novo Nordisk Isn't One.
07:43am, Tuesday, 16'th Jan 2024
Drug stocks GSK, Sanofi, Merck KGaA, and Novartis look set for a good year on strong cash flows and attractive valuations, says UBS.
2 biotechs with promising weight-loss drugs coming
07:01am, Tuesday, 16'th Jan 2024
Clinical weight-loss medications have been making headlines. GLP-1 drugs like Novo Nordisk A/S NYSE: NVO owned Ozempic and Wegovy and Eli Lilly and Co. NYSE: LLY owned Mounjaro and Zepbound contin
Here is Why Growth Investors Should Buy Novo Nordisk (NVO) Now
02:17pm, Monday, 15'th Jan 2024
Novo Nordisk (NVO) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Novo Nordisk (NVO) Is Up 2.45% in One Week: What You Should Know
01:32pm, Monday, 15'th Jan 2024
Does Novo Nordisk (NVO) have what it takes to be a top stock pick for momentum investors? Let's find out.
Weight loss drug hype to show no signs of slowing this year - analysts
10:47am, Monday, 15'th Jan 2024
Weight loss drugs are set to remain well in focus of investors this year, as the rollout of such treatment looks to even affect the food industry, Liberum analysts say. Following Novo Nordisk (NYSE:NV
